Pura Vida Investments’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-106,629
| Closed | -$1.22M | – | 61 |
|
|
2022
Q4 | $1.22M | Sell |
106,629
-170,000
| -61% | -$1.95M | 0.06% | 63 |
|
|
2022
Q3 | $3.49M | Sell |
276,629
-87,623
| -24% | -$1.1M | 0.2% | 51 |
|
|
2022
Q2 | $3.85M | Buy |
+364,252
| New | +$3.85M | 0.22% | 42 |
|
|
2021
Q1 | – | Sell |
-412,419
| Closed | -$3.07M | – | 159 |
|
|
2020
Q4 | $3.07M | Sell |
412,419
-309,500
| -43% | -$2.31M | 0.11% | 75 |
|
|
2020
Q3 | $2.48M | Buy |
721,919
+285,419
| +65% | +$980K | 0.13% | 66 |
|
|
2020
Q2 | $2.08M | Buy |
+436,500
| New | +$2.08M | 0.2% | 57 |
|
|
2020
Q1 | – | Sell |
-2,179,950
| Closed | -$7.52M | – | 70 |
|
|
2019
Q4 | $7.52M | Buy |
+2,179,950
| New | +$7.52M | 0.66% | 19 |
|
|
2018
Q4 | – | Sell |
-101,245
| Closed | -$773K | – | 57 |
|
|
2018
Q3 | $773K | Buy |
+101,245
| New | +$773K | 0.16% | 50 |
|
|
2017
Q4 | – | Sell |
-150,000
| Closed | -$786K | – | 49 |
|
|
2017
Q3 | $786K | Buy |
150,000
+50,000
| +50% | +$262K | 0.23% | 44 |
|
|
2017
Q2 | $556K | Buy |
+100,000
| New | +$556K | 0.22% | 47 |
|